//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Congrats to the team @travererare.bsky.social!
2mo
Greg Matthews
Shrugging off an earlier phase 3 disappointment, #Travere’s #Filspari has become the first FDA-approved treatment for #rarekidneydisease #focalsegmentalglomerulosclerosis (FSGS). pharmaphorum.com/news/travere...
2mo
Travere claims first FDA OK in rare kidney disease FSGS
Shrugging off an earlier phase 3 disappointment, Travere’s Filspari has become the first FDA-approved treatment for rare kidney disease FSGS.
pharmaphorum.com
pharmaphorum